Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Study confirms benefit of surgical treatment for migraines

Dr. Oren Tessler, Assistant Professor of Clinical Surgery at LSU Health Sciences Center New Orleans School of Medicine, is part of a team of plastic and reconstructive surgeons who report a high success rate using a method to screen and select patients for a specific surgical migraine treatment technique.

1 Aug 2014

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S.

29 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

Taiwan researchers develop new optical device to detect early complication of diabetes sooner

A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.

29 Jul 2014

EMA recommends full marketing approval for IMBRUVICA in the European Union

Pharmacyclics, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion recommending the granting of full marketing approval for IMBRUVICA (ibrutinib) in the European Union.

25 Jul 2014

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary, today announced that an investigational Phase 3 trial of NEXAVAR (sorafenib) tablets in patients with advanced breast cancer did not meet its primary endpoint of improving progression-free survival (PFS).

25 Jul 2014

FDA approves Targiniq ER to treat severe pain

Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

24 Jul 2014

Wake Forest Baptist shares tips to help avoid heat-related illnesses

Working out when it's hot isn't such a hot idea. Just ask Bret Nicks, M.D., associate professor of emergency medicine at Wake Forest Baptist Medical Center.

24 Jul 2014

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers.

24 Jul 2014

Pilot study shows that anti-cancer drug can activate hidden HIV

A pilot study by HIV researchers from Aarhus University and Aarhus University Hospital in Denmark has shown that an anti-cancer drug can activate hidden HIV.

23 Jul 2014

Correlation between sensitivity to light or noise and increased emotional symptoms in concussed teens

Two researchers from the University of Kentucky have demonstrated a connection between sensitivity to light or noise and increased emotional symptoms in teens who have suffered a concussion.

21 Jul 2014

Researchers use safer method to stimulate ovulation in women undergoing IVF treatment

Researchers have successfully used a new and potentially safer method to stimulate ovulation in women undergoing IVF treatment.

21 Jul 2014

FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

The U.S. Food and Drug Administration yesterday approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).

18 Jul 2014

FDA designated Astellas’ isavuconazole as QIDP for treatment of invasive candidiasis

Astellas today announced that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive candidiasis, a life-threatening, invasive fungal infection.

17 Jul 2014

Once-a-day pill for patients experiencing opioid-induced constipation

Opioids - strong morphine-based painkillers - are widely prescribed to patients experiencing chronic severe pain. While these drugs are very effective for treating and managing pain, they have one particularly bothersome side effect: constipation.

17 Jul 2014

Acupuncture can affect severity of hot flashes for women in natural menopause

In the 2,500+ years that have passed since acupuncture was first used by the ancient Chinese, it has been used to treat a number of physical, mental and emotional conditions including nausea and vomiting, stroke rehabilitation, headaches, menstrual cramps, asthma, carpal tunnel, fibromyalgia and osteoarthritis, to name just a few.

15 Jul 2014

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis.

14 Jul 2014

Reduction in alcohol consumption beneficial for cardiovascular health

A reduction in alcohol consumption, even for light-to-moderate drinkers, could be linked to improved cardiovascular health, including a reduced risk of coronary heart disease, lower body mass index and blood pressure, according to new research published in The BMJ.

14 Jul 2014

First step in developing evidence-based concussion guidelines

A research review identifying the clinical indicators most strongly associated with concussion is an important first step in the process of developing evidence-based guidelines for concussion diagnosis, prognosis, and treatment, according to a new report published by Neurosurgery, official journal of the Congress of Neurological Surgeons.

11 Jul 2014

Nausea News and Research

Further Reading

Study confirms benefit of surgical treatment for migraines

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Taiwan researchers develop new optical device to detect early complication of diabetes sooner

EMA recommends full marketing approval for IMBRUVICA in the European Union

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

FDA approves Targiniq ER to treat severe pain

Wake Forest Baptist shares tips to help avoid heat-related illnesses

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

Pilot study shows that anti-cancer drug can activate hidden HIV

Correlation between sensitivity to light or noise and increased emotional symptoms in concussed teens

Researchers use safer method to stimulate ovulation in women undergoing IVF treatment

FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

FDA designated Astellas’ isavuconazole as QIDP for treatment of invasive candidiasis

Once-a-day pill for patients experiencing opioid-induced constipation

Acupuncture can affect severity of hot flashes for women in natural menopause

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Reduction in alcohol consumption beneficial for cardiovascular health

First step in developing evidence-based concussion guidelines

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News